Christian R. Engwerda

Christian R. Engwerda

Auto-generated profile, based on publicly available information

Christian R. Engwerda

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2017 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YGYulong Gao
Yulong Gao
Fernando Souza-Fonseca-GuimaraesFernando Souza-Fonseca-Guimaraes
Fernando Souza-Fonseca-Guimaraes
TBTobias Bald
Tobias Bald
SNSusanna S Ng
Susanna S Ng
AYArabella Young
Arabella Young
MSMark J Smyth
Mark J Smyth

31 March 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
TLTapio Lönnberg
Tapio Lönnberg
VSValentine Svensson
Valentine Svensson
KJKylie Renee James
Kylie Renee James
Daniel Fernandez RuizDaniel Fernandez Ruiz
Daniel Fernandez Ruiz
ISIsmail Sebina
Ismail Sebina
STSarah A. Teichmann
Sarah A. Teichmann
Differentiation of naïve CD4+ T cells into functionally distinct T helper (TH) subsets is crucial for the orchestration of immune responses. Because of extensive heterogeneity and multiple overlapping transcriptional programs in differentiating T cell populations, this process has remained a challenge for systematic dissection in vivo. By using single-cell transcriptomics and computational analysis with a temporal mixtures of Gaussian processes model, termed GPfates, we reconstructed the developmental trajectories of TH1 and TFH (T follicular helper) cells during blood-stage Plasmodium infection in mice. By tracking clonality using endogenous T cell receptor sequences, we first demonstrated that TH1/TFH bifurcation had occurred at both population and single-clone levels. Next, we identified genes whose expression was associated with TH1 or TFH fates and demonstrated a T cell–intrinsic role for Galectin-1 in supporting TH1 differentiation. We also revealed the close molecular relationship between TH1 and interleukin-10–producing Tr1 cells in this infection. TH1 and TFH fates emerged from a highly proliferative precursor that up-regulated aerobic glycolysis and accelerated cell cycling as cytokine expression began. Dynamic gene expression of chemokine receptors around bifurcation predicted roles for cell-cell interaction in driving TH1/TFH fates. In particular, we found that precursor TH cells were coached toward a TH1 but not a TFH fate by inflammatory monocytes. Thus, by integrating genomic and computational approaches, our study has provided two unique resources: a database, www.PlasmoTH.org, which facilitates discovery of novel factors controlling TH1/TFH fate commitment, and, more generally, GPfates, a modeling framework for characterizing cell differentiation toward multiple fates.

1 October 2016 in Journal of Hepatology
Verified
Journal Article
Open access
LBLynette Beattie
Lynette Beattie
ASAmy Sawtell
Amy Sawtell
JMJason Mann
Jason Mann
TFTeija C.M. Frame
Teija C.M. Frame
BTBianca Teal
Bianca Teal
PKPaul M. Kaye
Paul M. Kaye
Kupffer cells (KCs), the resident tissue macrophages of the liver, play a crucial role in the clearance of pathogens and other particulate materials that reach the systemic circulation. Recent studies have identified KCs as a yolk sac-derived resident macrophage population that is replenished independently of monocytes in the steady state. Although it is now established that following local tissue injury, bone marrow derived monocytes may infiltrate the tissue and differentiate into macrophages, the extent to which newly differentiated macrophages functionally resemble the KCs they have replaced has not been extensively studied. We studied the two populations of KCs using intravital microscopy, morphometric analysis and gene expression profiling. An ion homeostasis gene signature, including genes associated with scavenger receptor function and extracellular matrix deposition, allowed discrimination between these two KC sub-types. Bone marrow derived "KCs" accumulating as a result of genotoxic injury, resemble but are not identical to their yolk sac counterparts. Reflecting the differential expression of scavenger receptors, yolk sac-derived KCs were more effective at accumulating acetylated low density lipoprotein, whereas surprisingly, they were poorer than bone marrow-derived KCs when assessed for uptake of a range of bacterial pathogens. The two KC populations were almost indistinguishable in regard to i) response to lipopolysaccharide challenge, ii) phagocytosis of effete red blood cells and iii) their ability to contain infection and direct granuloma formation against Leishmania donovani, a KC-tropic intracellular parasite. Bone marrow-derived KCs differentiate locally to resemble yolk sac-derived KC in most but not all respects, with implications for models of infectious diseases, liver injury and bone marrow transplantation. In addition, the gene signature we describe adds to the tools available for distinguishing KC subpopulations based on their ontology. Liver macrophages play a major role in the control of infections in the liver and in the pathology associated with chronic liver diseases. It was recently shown that liver macrophages can have two different origins, however, the extent to which these populations are functionally distinct remains to be fully addressed. Our study demonstrates that whilst liver macrophages share many features in common, regardless of their origin, some subtle differences in function exist. Gene expression data are available from the European Bioinformatics Institute ArrayExpress data repository (accession number E-MTAB-4954).

29 November 2011 in Nature Medicine
Verified
Journal Article
Closed access
MKMotoko Koyama
Motoko Koyama
RKRachel D Kuns
Rachel D Kuns
SOStuart D Olver
Stuart D Olver
NRNeil C Raffelt
Neil C Raffelt
YWYana A Wilson
Yana A Wilson
GHGeoffrey R Hill
Geoffrey R Hill

5 December 2006 in Immunology & Cell Biology
Verified
Journal Article
Closed access
ASAmanda C Stanley
Amanda C Stanley
CEChristian R Engwerda
Christian R Engwerda

26 August 2014 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
KAKylie A. Alexander
Kylie A. Alexander
RFRyan Flynn
Ryan Flynn
KLKatie E. Lineburg
Katie E. Lineburg
RKRachel D. Kuns
Rachel D. Kuns
BTBianca E. Teal
Bianca E. Teal
KMKelli P.A. MacDonald
Kelli P.A. MacDonald
Chronic GVHD (cGVHD) is the major cause of late, nonrelapse death following stem cell transplantation and characteristically develops in organs such as skin and lung. Here, we used multiple murine models of cGVHD to investigate the contribution of macrophage populations in the development of cGVHD. Using an established IL-17–dependent sclerodermatous cGVHD model, we confirmed that macrophages infiltrating the skin are derived from donor bone marrow (F4/80+CSF-1R+CD206+iNOS–). Cutaneous cGVHD developed in a CSF-1/CSF-1R–dependent manner, as treatment of recipients after transplantation with CSF-1 exacerbated macrophage infiltration and cutaneous pathology. Additionally, recipients of grafts from Csf1r–/– mice had substantially less macrophage infiltration and cutaneous pathology as compared with those receiving wild-type grafts. Neither CCL2/CCR2 nor GM-CSF/GM-CSFR signaling pathways were required for macrophage infiltration or development of cGVHD. In a different cGVHD model, in which bronchiolitis obliterans is a prominent manifestation, F4/80+ macrophage infiltration was similarly noted in the lungs of recipients after transplantation, and lung cGVHD was also IL-17 and CSF-1/CSF-1R dependent. Importantly, depletion of macrophages using an anti–CSF-1R mAb markedly reduced cutaneous and pulmonary cGVHD. Taken together, these data indicate that donor macrophages mediate the development of cGVHD and suggest that targeting CSF-1 signaling after transplantation may prevent and treat cGVHD.